Treatment Adjustments for 15-Year-Old Female with Poorly Controlled Type 2 Diabetes
The current treatment regimen for this adolescent patient with type 2 diabetes should be intensified by increasing the metformin dose to 1000 mg twice daily and adding a rapid-acting insulin before meals, while maintaining the basal insulin glargine (Lantus) at bedtime. 1
Current Status Assessment
- 15-year-old female with type 2 diabetes
- Current therapy: Lantus 40 units at bedtime and metformin 500 mg twice daily
- Non-fasting glucose: 255 mg/dL
- HbA1c: 11.1% (indicating very poor glycemic control)
Treatment Modifications
Metformin Adjustment
- Increase metformin from 500 mg twice daily to 1000 mg twice daily 2
- Titration schedule:
Insulin Therapy Intensification
- Continue Lantus 40 units at bedtime 4
- Add rapid-acting insulin (lispro, aspart, or glulisine) before meals 1
Rationale for Treatment Approach
- With HbA1c >9%, more aggressive therapy is required 1
- For adolescents with significantly elevated HbA1c (>10%), combination therapy with insulin is strongly indicated 1
- The combination of basal insulin with mealtime insulin is more effective for patients with severe hyperglycemia 1
- Metformin should be continued as it is the foundation of therapy for type 2 diabetes in adolescents 1
Monitoring and Follow-up
- Self-monitoring of blood glucose before meals and at bedtime 1
- Adjust rapid-acting insulin doses based on pre-meal glucose readings 1
- If pre-meal glucose values are >150 mg/dL in 50% of readings over 2 weeks, increase the dose 1
- If >2 pre-meal glucose values/week are <90 mg/dL, decrease the dose 1
- Re-check HbA1c in 3 months 1
Special Considerations for Adolescents
- Ensure proper education on insulin administration, glucose monitoring, and hypoglycemia management 1
- Consider potential adherence issues in adolescents 3
- Emphasize the importance of lifestyle modifications alongside medication adjustments 1
- Screen for diabetes complications, especially given the high HbA1c level 1
Potential Pitfalls and How to Avoid Them
- Risk of hypoglycemia with intensified insulin therapy: Start with conservative doses and educate on hypoglycemia recognition and treatment 1
- Gastrointestinal side effects with increased metformin: Gradual dose titration and taking with meals 1, 2
- Weight gain with insulin: Continue metformin as it is weight-neutral or promotes modest weight loss 1
- Adherence challenges: Consider once-daily extended-release metformin if twice-daily dosing is problematic 3
- Drug interactions: Monitor for medications that may increase hypoglycemia risk when combined with insulin 5
This treatment approach addresses the severe hyperglycemia while providing a structured plan for dose adjustments based on glucose monitoring results, which is essential for achieving target glycemic control in this adolescent patient.